FIELD: medicine. SUBSTANCE: it is suggested to apply TNF-alpha as the preparation for treating a mammal with polycystic renal disease due to intra-abdominal injection and the method for treatment due to its application. The innovation broadens the quantity of preparations of the mentioned function. EFFECT: higher efficiency of therapy. 3 cl, 3 ex, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD AND COMPOSITION FOR TREATING CANCER | 2011 |
|
RU2541100C2 |
| REDUCTION OF ARGINASE LEVELS/ACTIVITY | 2007 |
|
RU2469742C2 |
| METHODS OF TREATING POLYCYSTIC KIDNEY DISEASE | 2016 |
|
RU2742300C2 |
| FACTOR EFFECTING ON ACTIVITY OF TUMOR NECROSIS FACTOR RECEPTOR-RELEASING ENZYME | 1999 |
|
RU2279478C2 |
| USE OF ACYLFULVEN ANALOGS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1994 |
|
RU2145849C1 |
| METHOD FOR TREATING NEURODEGENERATIVE DISORDER OR MYELINOGENESIS DISORDER | 1997 |
|
RU2266129C2 |
| METHODS OF MITOCHONDRIAL MALFUNCTIONS | 2000 |
|
RU2394580C2 |
| ADENO-ASSOCIATED VIRUS VECTOR FOR THERAPEUTIC DELIVERY INTO THE CENTRAL NERVOUS SYSTEM | 2016 |
|
RU2751952C2 |
| METHOD FOR TREATING MITOCHONDRIAL DISORDERS | 2000 |
|
RU2268732C2 |
| MODULATION OF AQUAPORINS WITH RELAXIN | 2011 |
|
RU2564900C2 |
